Concepedia

Heta Jadhav

HJ

Statistics

Publications

2

Citations

57

H-Index

2

Active since

2022

Affiliations

Beth Israel Deaconess Medical Center(Current)

Cancer Research Institute

Dana-Farber/Harvard Cancer Center

Harvard University

Bayer (United States)

Heta Jadhav is an author at Beth Israel Deaconess Medical Center specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2022–2023

2

Publications

2

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer

Constantia Pantelidou, Heta Jadhav, Aditi Kothari et al. · npj Breast Cancer · 2022 · 35 citations · Full text

, , +17

RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou et al. · Nature Communications · 2023 · 22 citations · Full text

, , +17

1–2 of 2